Capital increase of euro 140 million to support the new 2022 – 2024 strategic business plan

Investor, News

Investment agreement signed with CDP Equity

The goals that Gpi intends to achieve through the implementation of the new Plan are:

  • to consolidate and increase the Company’s presence in the domestic market through the development of an offering that responds to innovation in care models through digital transformation and through a people-centred focus;
  • to gain leadership in Virtual Care (telemedicine), enhancing the approach that places the patient at the centre, through a proposition of solutions that enable the secure management of health data, paying particular attention to cybersecurity, in line with the strategic priorities of the NRRP;
  • to strengthen Gpi’s positioning internationally, particularly on the European and American continents, with primary focus in transfusion and drug automation;
  • to continue to invest in innovation to anticipate new product solutions in an ever-changing market, to be distinctive from competitors, also leveraging artificial intelligence to make Gpi solutions predictive and decision-supportive

The plan is to achieve revenues of more than euro 500 mln in 2024 (CAGR 21-24 >15%), including at least euro 420 mln in organic revenues and at least euro 80 mln in growth through external lines, with an EBITDA margin of more than 17%.

Press release